isibhengezo_sekhasi

Imikhiqizo

2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Impushana ecwebezelayo emhlophe/ephuzi ngokuphaphathekile

Incazelo emfushane:

Inombolo Yekhathalogi: XD90154
I-Cas: 298-96-4
I-Molecular Formula: I-C19H15N4·Cl
Isisindo se-Molecular: 334.80
Ukutholakala: Kukhona kusitoki
Inani:  
I-Prepack: 5g USD10
Iphakethe lenqwaba: Cela i-Quote

 

 

 

 

 

 

 


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

Inombolo Yekhathalogi XD90154
Igama Lomkhiqizo 2,3,5-Triphenyl-2H-tetrazolium chloride
I-CAS 298-96-4
I-Molecular Formula I-C19H15N4·Cl
Isisindo samangqamuzana 334.80
Imininingwane Yesitoreji 2 kuya ku-8 °C
Ikhodi Yentela Evumelanisiwe 29339980

 

Ukucaciswa Komkhiqizo

Ukubukeka Impushana ecwebezelayo emhlophe-emhlophe/ephuzi
U-Asay Okuncane.98%
I-Melting Point 235 - 245 Deg C
Ukulahlekelwa Ekumisweni <3.0%
Okuqukethwe Amanzi 0.5% Ubukhulu
Izinsalela ekushiseni Ubukhulu.0.5%
I-Solubility ku-EtoH Dlula
Ukuncibilika ku-Ethanol Icacile futhi iphelele

 

 

Ukuze uphenye umphumela onenzuzo wenhlanganisela ye-butyrate, i-Lactobacillus casei, ne-L-carnitine kumodeli ye-rat colitis.Amagundane ahlukaniswe ngamaqembu ayisikhombisa.Amaqembu amane athole i-butyrate yomlomo, i-L-carnitine, i-Lactobacillus casei kanye nokuhlanganiswa kwama-ejenti amathathu ngezinsuku ze-10 ezilandelanayo.Amaqembu asele afaka phakathi izilawuli ezingezinhle nezihle kanye neqembu mbumbulu.I-Macroscopic, ukuhlolwa kwe-histopathological, kanye nama-biomarker afana ne-tumor necrosis factor-alpha (TNF-α) ne-interlukin-1β (IL-1β), i-myeloperoxidase (MPO), i-thiobarbituric acid reactive substances (TBARS), kanye nekhono elincishisiwe le-plasma (FRAP) ) kwanqunywa kukholoni.Ukwelashwa okuhlangene kubonise umphumela ozuzisayo obalulekile ekunciphiseni ukuqunjelwa kwe-colitis uma kuqhathaniswa nezilawuli.Izinguquko eziphelele ekunciphiseni kwe-TNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg/mg amaprotheni, P <0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg/mg amaprotheni, P2 <0. ± 0.03 vs 0.49 ± 0.04 μg/mg iphrotheni, P <0.01), MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U/mg amaprotheni, P <0.05), kanye nokuphakama kwe-FRAP (23.46 ± 1.3 μmo ± 7/7 vs 1.3 L. , P <0.05) isekela okuthandwayo kokwelashwa okuhlangene ngokuqhathaniswa nezilawuli.Nakuba ama-monotherapies nawo asebenza kahle ekuthuthukiseni izimpawu zokuqunjelwa, ukwelapha okuhlanganisiwe bekungcono kakhulu ekuthuthukiseni izimpawu zokucindezeleka ze-colon oxidative ezihlanganisa i-FRAP, TBARS, kanye ne-MPO. isimo somtholampilo.


  • Okwedlule:
  • Olandelayo:

  • Vala

    2,3,5-Triphenyl-2H-tetrazolium chloride Cas:298-96-4 98% Impushana ecwebezelayo emhlophe/ephuzi ngokuphaphathekile